In this context, the choice of the B16F10 melanoma cell model was also pertinent, since these cells produce relatively low levels of osteopontin [76,77], allowing us to achieve an increase in cOPN considerably above that elicited by the presence of the primary tumour alone. The gene discussed is SPP1; the disease is neoplasm.